Therapeutic Advances in Respiratory Disease

Edit Your Profile

Therapeutic Advances in Respiratory Disease Journal

publication venue for

Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy. 15. 2021
Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries 2020
Nintedanib in non-small cell lung cancer: From preclinical to approval 2015

International Standard Serial Number (ISSN)

1753-4658

Electronic International Standard Serial Number (EISSN)

1753-4666